From the GENIE dataset, we found more than 60 different forms of Ex20ins mutations, accounting for 16% of rare EGFR mutations and 6.2% of all EGFR mutations in NSCLC (Figure 2). Here, EGFR is linked to non-small cell lung carcinoma.